Internal Server Error

PostEra - About the company

PostEra is a series A company based in London (United Kingdom), founded in 2019 by Alpha Lee, Aaron Morris and Matthew Robinson. It operates as an AI based molecular designing software for drug discovery. PostEra has raised $26.2M in funding from Y Combinator and The Clermont. The company has 159 active competitors, including 38 funded and 15 that have exited. Its top competitors include companies like Certara, Astex Pharmaceuticals and Cartography Biosciences.

Company Details

AI-based molecular designing software for drug discovery It uses ML technology for designing molecular compounds to aid in the chemical synthesis of the compounds. It also enables the user to explore chemical space and optimize scaffolds of the lead compound, design the synthetic routes. The company also designs and enables users to order chemical compounds.
Website
postera.ai
Social
X
Email ID
*****@postera.ai, *****@postera.ai
Key Metrics
Founded Year
2019
Location
Stage
Series A
Total Funding
$26.2M in 2 rounds
Latest Funding Round
Ranked
Employee Count
41 as on Sep 30, 2026
Similar Companies
Sign up to download PostEra's company profile

PostEra's funding and investors

PostEra has raised a total funding of $26.2M over 2 rounds. Its first funding round was on Mar 17, 2020. Its latest funding round was a Series A round on Jan 11, 2022 for $*****. 10 investors participated in its latest round. PostEra has 10 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of PostEra:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 11, 2022
1770667
Series A
1882724
8232246
7943316
2505046
Mar 17, 2020
6864762
Seed
8503594
3448078
2665258
lockAccess funding benchmarks and valuations. Sign up today!

PostEra's founders and board of directors

Founder? Claim Profile
The founders of PostEra are Alpha Lee, Aaron Morris and Matthew Robinson. Aaron Morris is the CEO of PostEra.
Here are the details of PostEra's key team members:

PostEra's Board of Directors

PostEra's board has 3 active members. Matthew Robinson, Alpha Lee and Aaron Morris are part of team.
Here is the list of PostEra's board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
6y 11m
Team
-
Current
6y 11m
Team
-
Current
6y 11m

PostEra's employee count trend

PostEra has 41 employees as of Sep 26. Here is PostEra's employee count trend over the years:
Employee count trend for PostEra
lockUncover PostEra's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

PostEra's Competitors and alternates

Top competitors of PostEra include Certara, Astex Pharmaceuticals and Cartography Biosciences. Here is the list of Top 10 competitors of PostEra, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Certara
Certara
2008, Princeton (United States), Public
Provider of a platform for in silico drug discovery and consulting services
-
65/100
2nd
Logo for Astex Pharmaceuticals
Astex Pharmaceuticals
1991, Pleasanton (United States), Acquired
Oncology and CNS drug discovery and development using cutting-edge technology
$3M
64/100
3rd
Logo for Cartography Biosciences
Cartography Biosciences
2020, Foster City (United States), Series B
Provider of a platform to discover immunotherapeutics
$124M
63/100
4th
Logo for Pharmacelera
Pharmacelera
2015, Barcelona (Spain), Series A
Hardware and software solutions for computer-aided drug design
$7.1M
59/100
5th
Logo for Oxford Drug Design
Oxford Drug Design
2001, Oxford (United Kingdom), Series A
Provider of computer-aided design of antibiotics for MDR infections
$12.4M
59/100
6th
Logo for Inpharmatica
Inpharmatica
1998, London (United Kingdom), Acquired
Developer of predictive informatics based platform for drug discovery
$75M
58/100
7th
Logo for Genialis
Genialis
2015, Boston (United States), Series A
Developer of end-to-end bioinformatics software solutions
$16M
56/100
8th
Logo for CytoReason
CytoReason
2016, Haifa (Israel), Series C
Discovering immune system based drugs by biological data analytics
$130M
55/100
9th
Logo for BioMap
BioMap
2020, Beijing (China), Series A
AI-based precision medicine supporting tool for drug discovery
-
56/100
10th
Logo for PostEra
PostEra
2019, London (United Kingdom), Series A
AI based molecular designing software for drug discovery
$26.2M
51/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on PostEra's competitors? Click here to see the top ones

PostEra's Investments and acquisitions

PostEra has made no investments or acquisitions yet.

Reports related to PostEra

Here is the latest report on PostEra's sector:

News related to PostEra

lockFilter this list
•
PostEra and NIH partner for AI-powered antiviral developmentPharmaceutical Technology•May 19, 2022•PostEra, NIH
•
The tiny Boston startup helping Pfizer with Covid-19 antiviralsThe Business Journals•Jan 18, 2022•PostEra, Pfizer
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about PostEra

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford